Abeona Therapeutics Inc (NASDAQ:ABEO) currently has a daily average trading volume of 1.55M but it saw 2665714 shares traded in last market. With a market cap of 329.96M USD, the company’s current market price of $6.45 came rising about 0.47 while comparing to the previous closing price of $6.42. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.32 and as low as $3.93.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Oppenheimer which initiated the stock as “Outperform” in its note to investors issued on March 05, 2025, recommending a price target of $16 for it. Stifel also issued its recommendations for the stock as it initiated the price target for the stock is $21.
Over the week, ABEO’s stock price is moving 19.67% up while it is 22.16% when we observe its performance for the past one month. Year-to-date it is 15.80% up and over the past year, the stock is showing an upside performance of 46.59%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.38 while estimate for next year EPS is -1.06. In next quarter, company is expected to be making quarterly sales of $6.61M as analysts are expecting the sales for current fiscal year at $47.91M and seeing the company making $107.35M in sales next year. Moreover, analysts are in estimates of $21.71M for current-quarter revenue.
Currently, Abeona Therapeutics Inc’s total number of outstanding shares is 48.95M with 6.59% of that held by the insiders while 66.21% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -78.05% and return on equity (ROE) at -271.78%. It has a 27.10 of forward P/E ratio. Stock’s beta reads 1.57. Stock has a price to book (P/B) ratio of 7.63. Its return on asset (ROA) is -50.73% on average.
